Lipocine Stock Market Value
| LPCN Stock | USD 8.67 0.01 0.12% |
| Symbol | Lipocine |
Will Pharmaceuticals sector continue expanding? Could Lipocine diversify its offerings? Factors like these will boost the valuation of Lipocine. Expected growth trajectory for Lipocine significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Lipocine data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.02) | Revenue Per Share | Quarterly Revenue Growth 5.954 | Return On Assets | Return On Equity |
Understanding Lipocine requires distinguishing between market price and book value, where the latter reflects Lipocine's accounting equity. The concept of intrinsic value - what Lipocine's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Lipocine's price substantially above or below its fundamental value.
Understanding that Lipocine's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Lipocine represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Lipocine's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Lipocine 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lipocine's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lipocine.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Lipocine on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Lipocine or generate 0.0% return on investment in Lipocine over 90 days. Lipocine is related to or competes with OSR Holdings, Adlai Nortye, BioLineRx, GeoVax Labs, Edesa Biotech, ProMIS Neurosciences, and Eterna Therapeutics. Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the... More
Lipocine Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lipocine's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lipocine upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.59 | |||
| Information Ratio | 0.2739 | |||
| Maximum Drawdown | 33.09 | |||
| Value At Risk | (7.33) | |||
| Potential Upside | 15.95 |
Lipocine Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lipocine's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lipocine's standard deviation. In reality, there are many statistical measures that can use Lipocine historical prices to predict the future Lipocine's volatility.| Risk Adjusted Performance | 0.2383 | |||
| Jensen Alpha | 1.89 | |||
| Total Risk Alpha | 1.38 | |||
| Sortino Ratio | 0.3944 | |||
| Treynor Ratio | (6.27) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lipocine's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lipocine February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.2383 | |||
| Market Risk Adjusted Performance | (6.26) | |||
| Mean Deviation | 4.8 | |||
| Semi Deviation | 3.17 | |||
| Downside Deviation | 4.59 | |||
| Coefficient Of Variation | 351.57 | |||
| Standard Deviation | 6.61 | |||
| Variance | 43.67 | |||
| Information Ratio | 0.2739 | |||
| Jensen Alpha | 1.89 | |||
| Total Risk Alpha | 1.38 | |||
| Sortino Ratio | 0.3944 | |||
| Treynor Ratio | (6.27) | |||
| Maximum Drawdown | 33.09 | |||
| Value At Risk | (7.33) | |||
| Potential Upside | 15.95 | |||
| Downside Variance | 21.06 | |||
| Semi Variance | 10.08 | |||
| Expected Short fall | (5.81) | |||
| Skewness | 1.08 | |||
| Kurtosis | 1.44 |
Lipocine Backtested Returns
Lipocine is moderately volatile given 3 months investment horizon. Lipocine has Sharpe Ratio of 0.26, which conveys that the firm had a 0.26 % return per unit of risk over the last 3 months. We were able to break down twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.74% are justified by taking the suggested risk. Use Lipocine Downside Deviation of 4.59, risk adjusted performance of 0.2383, and Mean Deviation of 4.8 to evaluate company specific risk that cannot be diversified away. Lipocine holds a performance score of 20 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -0.3, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Lipocine are expected to decrease at a much lower rate. During the bear market, Lipocine is likely to outperform the market. Use Lipocine value at risk, as well as the relationship between the skewness and day median price , to analyze future returns on Lipocine.
Auto-correlation | -0.23 |
Weak reverse predictability
Lipocine has weak reverse predictability. Overlapping area represents the amount of predictability between Lipocine time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lipocine price movement. The serial correlation of -0.23 indicates that over 23.0% of current Lipocine price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.23 | |
| Spearman Rank Test | -0.26 | |
| Residual Average | 0.0 | |
| Price Variance | 1.37 |
Pair Trading with Lipocine
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lipocine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will appreciate offsetting losses from the drop in the long position's value.Moving against Lipocine Stock
| 0.64 | KG | Kestrel Group Symbol Change | PairCorr |
| 0.51 | 21P | Aurora Cannabis | PairCorr |
| 0.5 | IQ70 | 1CM INC | PairCorr |
| 0.36 | ELTX | Elicio Therapeutics | PairCorr |
| 0.33 | NXS | Next Science | PairCorr |
The ability to find closely correlated positions to Lipocine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lipocine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lipocine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lipocine to buy it.
The correlation of Lipocine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lipocine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lipocine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lipocine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Lipocine Correlation, Lipocine Volatility and Lipocine Performance module to complement your research on Lipocine. To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Lipocine technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.